Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis

Recruiting N/A Interventional Study
Schizophrenia Disorders Treatment Resistant Hallucinations
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
30 (estimated)
Sponsor
Fundació Sant Joan de Déu · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study aims to evaluate the relationship between cognitive, metacognitive and social cognition variables in patients with psychosis undergoing VR-based Avatar Therapy for the treatment of auditory hallucinations. In addition to the primary intervention, participants will be assessed using validated tools for emotion recognition, attributional style, theory of mind, neurocognition, and metacogn…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
\*\*Inclusion Criteria:\*\* * Adults aged 18 years or older. * Diagnosis of schizophrenia spectrum disorder according to DSM-5 criteria. * Experience of persistent auditory hallucinations for at least 3 months (PANSS hallucination score ≥ 3). * Stable medication dosage for at least 4 weeks prior to…
Contacts

Susana Ochoa, PhD

+34936406350

susana.ochoa@sjd.es

CONTACT

Luciana Díaz-Cutraro, PhD

+34936406350

luciana.diaz@sjd.es

CONTACT